surpass cvot tirzepatide ACC 26: SURPASS-CVOT 💡 New insight in diabetes

Maldonado, S.N., Nez, V.P., Vzquez, S.A., Cortias, M.M

This mechanism suggests BPC-157 functions as a cellular sensitizer to endogenous growth factors rather than as a direct growth factor itself

The SURMOUNT-4 trial examined weight maintenance, showing that participants who continued tirzepatide after initial weight loss maintained and even extended their results, while those switched to placebo regained 14% of lost weight during the follow-up period

Fiber strategies that account for reduced food intake

Mounjaro, which contains the active ingredient tirzepatide, is a prescription medication approved by the FDA explicitly for managing type 2 diabetes in adults

This dedication to quality care and convenience is what sets us apart in the field of Chicago weight loss